Find verified Ec-5026 API manufacturers, suppliers, and distributors across the globe. Explore companies that offer high-purity Ec-5026 for pharmaceutical use, along with product details, certifications, and reliable sourcing options. Compare prices, check availability, and connect directly with trusted suppliers for Ec-5026 API.
Alternate Names: D5X8A5HWL0, BPN-19186, UNII-D5X8A5HWL0, CHEMBL4752759
CAS No: 1809885-32-2
PubChem CID: 91933845
Mol Formula: C18H23F4N3O3
Mol Weight: 405.4 g/mol
IUPAC Name: 1-[3-fluoro-4-(trifluoromethoxy)phenyl]-3-[1-[(2S)-2-methylbutanoyl]piperidin-4-yl]urea
API Description: The compound EC5026, also known as BPN-19186, is a potent, orally bioavailable inhibitor of soluble epoxide hydrolase (sEH). This enzyme plays a crucial role in the metabolism of fatty acid epoxides, which are involved in various physiological processes, including inflammation and pain modulation. Pain Management: EC5026 has been investigated for its efficacy in treating various pain conditions, including those in veterinary settings, such as in dogs, cats, and horses. Neurological Research: The compound is being explored for its potential in treating neurological disorders like Parkinson’s disease and dementia with Lewy bodies.
